Seattle Genetics | SGEN - Credores Comerciais



Credores Comerciais Alterar Data
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Amgen USD 20.89B 1.25B 2025-12
Astellas Pharma JPY 181.95B 13.3B 2025-12
Bayer EUR 7.08B 700M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Genmab DKK 6M 2M 2025-09
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 20.72B 346.14M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Insmed USD 79.91M 316K 2025-12
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
MacroGenics USD 4.79M 1.15M 2025-12
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xencor USD 10.83M 1.75M 2025-12